NIPH
BMY.RT

NN Investment Partners Holdings’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

NN Investment Partners Holdings’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-20,348
Closed – – 834
2020
Q4 		$0 Hold
20,348
– – ﹤0.01% 801
2020
Q3 		$46K Hold
20,348
– – ﹤0.01% 701
2020
Q2 		$1K Hold
20,348
– – ﹤0.01% 747
2020
Q1 		$1K Hold
20,348
– – ﹤0.01% 734
2019
Q4 		$0 Buy
+20,348
New +$52.9K ﹤0.01% 779

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

NN Investment Partners Holdings's BMY.RT Position: Q1 2021 in Review

NN Investment Partners Holdings sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 20,348 shares.

NN Investment Partners Holdings first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $46K in Q3 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • NN Investment Partners Holdings reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • NN Investment Partners Holdings sold 20,348 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021.
  • NN Investment Partners Holdings first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • NN Investment Partners Holdings's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $46K in Q3 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on NN Investment Partners Holdings's 13F filing for Q1 2021, filed 28 Apr 2021.